SEARCH

SEARCH BY CITATION

References

  • Banno, F., Kokame, K., Okuda, T., Honda, S., Miyata, S., Kato, H., Tomiyama, Y. & Miyata, T. (2006) Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood, 107, 31613166.
  • Camilleri, R.S., Cohen, H., Mackie, I.J., Scully, M., Starke, R.D., Crawley, J.T., Lane, D.A. & Machin, S.J. (2008) Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis, 6, 331338.
  • Fujimura, Y., Matsumoto, M., Yoshioka, A., Matsui, T. & Titani, K. (2002) von Willebrand factor-cleaving protease and Upshaw–Schulman syndrome. In: Progress in Hematology. International Journal of Hematology, 75, 2534.
  • Furlan, M. & Lämmle, B. (2001) Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Practice & Research. Clinical Haematology, 14, 437454.
  • Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lämmle, B. (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New England Journal of Medicine, 339, 15781584.
  • Hara, T., Kitano, A., Kajiwara, T., Kondo, T., Sakai, K. & Hamasaki, Y. (1986) Factor VIII concentrate-responsive thrombocytopenia, hemolytic anemia, and nephropathy. Evidence that factor VIII: von Willebrand factor is involved in its pathogenesis. The American Journal of Pediatric Hematology/Oncology, 8, 324328.
  • Ishizashi, H., Yagi, H., Matsumoto, M., Soejima, K., Nakagaki, T. & Fujimura, Y. (2007) Quantitative Western blot analysis of plasma ADAMTS13 antigen in patients with Upshaw–Schulman syndrome. Thrombosis Research, 120, 381386.
  • Johnson, S.S., Montgomery, R.R. & Hathaway, W.E. (1981) Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation. British Journal of Haematology, 47, 597606.
  • Kato, S., Matsumoto, M., Matsuyama, T., Isonishi, A., Hiura, H. & Fujimura, Y. (2006) Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion, 46, 14441452.
  • Kinoshita, S., Yoshioka, A., Park, Y.-D., Ishizashi, H., Konno, M., Funado, M., Matsui, T., Titani, K., Yagi, H., Matsumoto, M. & Fujimura, Y. (2001) Upshaw–Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura. International Journal of Hematology, 74, 101108.
  • Kokame, K., Matsumoto, M., Soejima, K., Yagi, H., Ishizashi, H., Funato, M., Tamai, H., Konno, M., Kamide, K., Kawano, Y., Miyata, T. & Fujimura, Y. (2002) Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proceedings of the National Academy of Sciences of the United States of America, 99, 1190211907.
  • Kremer-Hovinga, J.A., Mäder, G., Lovey, P.Y., Morris, M.A., Oppliger-Leibundgut, E., Kuchler, H., Wermuth, B. & Lämmle, B. (2005) A second Swiss family with Upshaw–Schulman Syndrome (hereditary thrombotic thrombocytopenic purpura, TTP): Clinical course and molecular findings. Journal of Thrombosis and Haemostasis, 3(Suppl. 1), Abstract P1139.
  • Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniak, D.R., Stark, K.R., Gruppo, R., Sarode, R., Shurin, S.B., Chandrasekaran, V., Stabler, K.R., Sabio, H., Bouhassira, E.E., Upshaw, Jr, J.D., Ginburg, D. & Tsai, H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488494.
  • Matsumoto, M., Kokame, K., Soejima, K., Miura, M., Hayashi, S., Fujii, Y., Iwai, A., Ito, E., Tsuji, Y., Takeda-Shitaka, M., Iwadate, M., Umeyama, H., Yagi, H., Ishizashi, H., Banno, F., Nakagaki, T., Miyata, T. & Fujimura, Y. (2004) Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw–Schulman syndrome. Blood, 103, 13051310.
  • Moake, J.L. (2002) Thrombotic microangiopathies. New England Journal of Medicine, 347, 589600.
  • Motto, D.G., Chauhan, A.K., Zhu, G., Homeister, J., Lamb, C.B., Desch, K.C., Zhang, W., Tsai, H.M., Wagner, D.D. & Ginsburg, D. (2005) Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. Journal of Clinical Investigation, 115, 27522761.
  • Scully, M., Starke, R., Lee, R., Mackie, I., Machin, S. & Cohen, H. (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagulation and Fibrinolysis, 17, 459463.
  • Soejima, K., Nakamura, H., Hirashima, M., Morikawa, W., Nozaki, C. & Nakagaki, T. (2006) Analysis on the molecular species and concentration of circulating ADAMTS13 in blood. Journal of Biochemistry, 139, 147154.
  • Stirling, Y., Woolf, L., North, W.R., Seghatchian, M.J. & Meade, T.W. (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis, 52, 176182.
  • Terrell, D.R., Williams, L.A., Vesely, S.K., Lämmle, B., Hovinga, J.A. & George, J.N. (2005) The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. Journal of Thrombosis and Haemostasis, 3, 14321436.
  • Tsai, H.M., Sarode, R. & Downes, K.A. (2002) Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood. Thrombosis Research, 108, 121125.
  • Uemura, M., Tatsumi, K., Matsumoto, M., Fujimoto, M., Matsuyama, T., Ishikawa, M., Iwamoto, T., Mori, T., Wanana, A., Fukui, H. & Fujimura, Y. (2005) Localization of ADAMTS13 to the stellate cells of human liver. Blood, 106, 922924.
  • Vesely, S.K., Li, X., McMinn, J.R., Terrell, D.R. & George, J.N. (2004) Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion, 44, 11491158.
  • Veyradier, A., Bernadette, O., Haddad, E., Cloarec, S., Nivet, H., Foulard, M., Lesure, F., Delattre, P., Lakhdari, M., Meyer, D., Girma, J.-P. & Loriat, C. (2003) Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS13) activity in a subgroup of children with atypical hemolytic uremic syndrome. Journal of Pediatrics, 142, 310317.
  • Veyradier, A., Meyer, D. & Loriat, C. (2006) Desmopressin, an unexpected link between nocturnal enuresis and inherited thrombotic thrombocytopenic purpura (Upshaw–Schulman syndrome). Journal of Thrombosis and Haemostasis, 4, 700701.
  • Weiner, C.P. (1987) Thrombotic microangiopathy in pregnancy and the postpartum period. Seminars in Hematology, 24, 119129.
  • Yagi, H., Konno, M., Kinoshita, S., Matsumoto, M., Ishizashi, H., Matsui, T., Titani, K. & Fujimura, Y. (2001) Plasma of patients with Upshaw–Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress. British Journal of Haematology, 115, 991997.
  • Yagi, H., Ito, S., Kato, S., Hiura, H., Matsumoto, M. & Fujimura, Y. (2007) Plasma levels of ADAMTS13 antigen determined with an enzyme immunoassay using a neutralizing monoclonal antibody parallel ADAMTS13 activity levels. International Journal of Hematology, 85, 403407.